Z. Mark
Impact in
- Physiology top 10%
- Asthma and respiratory diseases
- Immunology top 10%
- IL-33, ST2, and ILC Pathways
Papers in
-
- Glycosylation and Glycoproteins Research 1
- Epigenetics and DNA Methylation 1
-
- Chromosomal and Genetic Variations 2
- Co-authors
- Rozsa Schlenker‐Herceg (1 shared paper)James Baker (1 shared paper)Peter J. Barnes (1 shared paper)Klaus F. Rabe (1 shared paper)Edward Kerwin (1 shared paper)Ildikó Horváth (1 shared paper)Rosemary Watt (1 shared paper)David Bernstein (1 shared paper)
- Journals
- ACS Chemical Biology (1 paper)Clinical Cancer Research (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)American Journal of Respiratory and Critical Care Medicine (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesHungaryChina
In The Last Decade
Z. Mark
9 papers receiving 833 citations
Peers
Comparison fields: 5 of 68
- Physiology 313
- Immunology 230
- Immunology and Allergy 60
- Cancer Research 106
- Pulmonary and Respiratory Medicine 186
Countries citing papers authored by Z. Mark
This map shows the geographic impact of Z. Mark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Z. Mark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Z. Mark more than expected).
Fields of papers citing papers by Z. Mark
This network shows the impact of papers produced by Z. Mark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Z. Mark. The network helps show where Z. Mark may publish in the future.
Co-authors
The 25 scholars most cited alongside Z. Mark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 393 | |
| 2 | 2011 | 212 | |
| 3 | 2015 | 99 | |
| 4 | 2012 | 55 | |
| 5 | 2013 | 48 | |
| 6 | 2017 | 46 | |
| 7 | 2015 | 9 | |
| 8 | 2014 | 4 | |
| 9 | 1981 | 2 |
About Z. Mark
Z. Mark is a scholar working on Molecular Biology, Plant Science, Organic Chemistry, Surgery and Pathology and Forensic Medicine, having authored 9 papers that have together received 868 indexed citations. Recurring topics across this work include Chromosomal and Genetic Variations (2 papers), Cancer Mechanisms and Therapy (1 paper), Glycosylation and Glycoproteins Research (1 paper), Epigenetics and DNA Methylation (1 paper), Immunotherapy and Immune Responses (1 paper), Liver Disease and Transplantation (1 paper), Neonatal Health and Biochemistry (1 paper) and MicroRNA in disease regulation (1 paper). The work is most often cited by research in Physiology (313 citations), Immunology (230 citations), Immunology and Allergy (60 citations), Cancer Research (106 citations) and Pulmonary and Respiratory Medicine (186 citations). Z. Mark has collaborated with scholars based in United States, Hungary and China. Frequent co-authors include Rozsa Schlenker‐Herceg, James Baker, Peter J. Barnes, Klaus F. Rabe, Edward Kerwin, Ildikó Horváth, Rosemary Watt, David Bernstein, Adam Antczak and Deborah A. Meyers. Their work appears in journals such as ACS Chemical Biology, Clinical Cancer Research, Journal for ImmunoTherapy of Cancer, American Journal of Respiratory and Critical Care Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.